Ratings by LifeSci Capital
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | N/A | Inhibrx Biosciences | INBX | New Coverage | Outperform (N/A) |
200.00 (N/A) |
119.93 (92.20) |
-23.12% | Details |
| 3/6/2026 | N/A | Jade Biosciences | JBIO | New Coverage | Outperform (N/A) |
24.00 (N/A) |
13.88 (15.34) |
10.52% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 40 more... | |||||||||
